Berwyn Clarke

Berwyn Clarke

Voorzitter bij
Novai Ltd.
70 jaar
Health Technology
Consumer Services
Commercial Services

Profiel

Berwyn Ewart Clarke was the founder of Lab 21 Ltd. (founded in 2005) and held the title of Director, Chief Scientific & Development Officer from 2012 to 2013.
Dr. Clarke is also the founder of Oneida TheraDiagnostics Ltd. Dr. Clarke's current job(s) include being the Chairman of Iceni Diagnostics Ltd., Co-Chairman of Novai Ltd., and Director of PBD Biotech Ltd. (since 2014).
Dr. Clarke's former job(s) include being the Interim Chief Executive Officer of Replizyme Ltd., Director of Glyconics Ltd. (from 2013 to 2023), and holding positions at Wellcome Plc and Virco Group.
Dr. Clarke obtained a doctorate degree from Imperial College London and an undergraduate degree from the University of Kent.

Actieve functies van Berwyn Clarke

BedrijvenFunctieBegin
Directeur/Bestuurslid 17-02-2014
Voorzitter -
Voorzitter -

Eerdere bekende functies van Berwyn Clarke

BedrijvenFunctieEinde
Directeur/Bestuurslid 29-08-2023
Oprichter 31-01-2013
Replizyme Ltd.
President -
Corporate Officer/Principal -
Corporate Officer/Principal -
Ervaring van Berwyn Clarke in detail bekijken

Opleiding van Berwyn Clarke

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

13

Eerstegraads connecties

11

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit11

Consumer Services

Commercial Services

Health Services

Health Services

Oneida TheraDiagnostics Ltd.

Replizyme Ltd.

Consumer Services

Health Technology

Health Technology

Health Technology

Commercial Services

  1. Beurs
  2. Insiders
  3. Berwyn Clarke